NCT05097638

Brief Summary

Some of pulmonary tuberculous patients who completed their medication course experience lung function impairment

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
210

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2018

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 20, 2018

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2019

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 4, 2020

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

October 7, 2021

Completed
21 days until next milestone

First Posted

Study publicly available on registry

October 28, 2021

Completed
Last Updated

October 28, 2021

Status Verified

October 1, 2021

Enrollment Period

1.8 years

First QC Date

October 7, 2021

Last Update Submit

October 16, 2021

Conditions

Keywords

pulmonary TuberculosisSpirometryPulmonary Function

Outcome Measures

Primary Outcomes (3)

  • Post tuberculosis lung functional impairment

    spirometry abnormality either: restrictive, obstructive, or mixed

    6 months

  • post tuberculosis persistent clinical symptoms

    either cough , sputum , breathlessness, hemoptysis

    6 months

  • Grading of obstruction function:

    grading according to GOLD : mild , moderate , severe , very severe

    6 months

Study Arms (1)

Cured pulmonary Tuberculosis patients

6 months after a completed course of anti-tuberculosis therapy

Diagnostic Test: spirometry

Interventions

spirometryDIAGNOSTIC_TEST

Patient do spirometry

Cured pulmonary Tuberculosis patients

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patient more than 18 years old had been newly diagnosed drug-sensitive first episode pulmonary tuberculosis, confirmed by sputum smear microscopy were included in the study. He completed an outpatient course of standard first line anti-tuberculosis therapy (6 months) and declared as cured without radiological change over the past year (in comparable with chest X-ray at the end of TB treatment).

You may qualify if:

  • Patient completed an outpatient course of standard first line anti-tuberculosis therapy and declared as cured

You may not qualify if:

  • Smoker (to avoid spirometry biases).
  • Extrapulmonary tuberculosis cases
  • Multidrug resistant tuberculosis
  • known contraindications to spirometry testing
  • Individuals with chest wall deformities or neuromuscular diseases
  • Patients who failed to achieve acceptability and reproducibility criteria of the spirometry test
  • Defaulter cases or irregular treatment,
  • known coexisting chronic lung disease as history of asthma or interstitial lung diseases
  • A history of illicit drug use
  • Patients with comorbidities: renal and hepatic insufficiency, heart diseases and metabolic disorders.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chest Department-faculty of medicine-Assuit university

Asyut, Egypt

Location

MeSH Terms

Conditions

Tuberculosis, PulmonaryAntisocial Personality Disorder

Interventions

Spirometry

Condition Hierarchy (Ancestors)

TuberculosisMycobacterium InfectionsActinomycetales InfectionsGram-Positive Bacterial InfectionsBacterial InfectionsBacterial Infections and MycosesInfectionsRespiratory Tract InfectionsLung DiseasesRespiratory Tract DiseasesPersonality DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Respiratory Function TestsDiagnostic Techniques, Respiratory SystemDiagnostic Techniques and ProceduresDiagnosis

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecture in Chest and Tuberculosis Department, Faculty of Medicine

Study Record Dates

First Submitted

October 7, 2021

First Posted

October 28, 2021

Study Start

January 20, 2018

Primary Completion

November 1, 2019

Study Completion

February 4, 2020

Last Updated

October 28, 2021

Record last verified: 2021-10

Locations